Receptor 'transactivation' in insulin signaling.
Receptor 'transactivation' in insulin signaling.
批准号:
6635311
负责人:
LOUIS M LUTTRELL
金额:
$10.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2003-11-14
关键词:
G protein adipocytes apoptosis biological signal transduction cell line cell proliferation epidermal growth factor fibroblasts genetic transcription growth factor receptors hormone regulation /control mechanism insulin insulinlike growth factor integrins ionizing radiation liver cells metalloendopeptidases mitogen activated protein kinase mixed tissue /cell culture muscle cells paracrine phosphatidylinositol 3 kinase protein tyrosine kinase receptor coupling
中文摘要
描述:(扫描自申请人摘要)对胰岛素的反应,
葡萄糖转运蛋白重新分布到质膜、葡萄糖和脂质
代谢转变为合成代谢模式,脂质激酶产生抗凋亡
信号和酪氨酸激酶刺激细胞生长。目前的模型建议
胰岛素反应是由内在配体刺激的酪氨酸
受体的激酶活性作用于一小部分酪氨酸
磷蛋白衔接子然而,最近的工作已经开始揭示广泛的
胰岛素家族受体与其他信号之间的串扰网络
包括异源三聚体G蛋白和经典受体酪氨酸的转换器
激酶。在这项提案中,我们提供了初步数据,表明IGF-1
受体刺激抗凋亡IRS 1/磷脂酰肌醇3-激酶/Akt
通过不同的细胞周期调控机制,
机制等而IGF- 1受体介导的IRS蛋白磷酸化
控制抗凋亡途径,IGF-1诱导的促有丝分裂信号需要
表皮生长因子(EGF)样配体从细胞表面的释放
和EGF受体的旁分泌“反式激活”。IGF- 1与
EGF受体是通过基质金属蛋白酶依赖的切割介导的,
肝素结合(HB)-EGF,也涉及百日咳毒素敏感的过程
异源三聚体G蛋白。该提案的主要目标是,
胰岛素/IGF-1受体,EGF受体,
和异源三聚体G蛋白,并确定这些蛋白的贡献,
转录调控和细胞增殖控制的机制
通过胰岛素和IGF- 1受体。本提案的一个具体目的是确定
胰岛素和IGF- 1受体调节基质的机制
金属蛋白酶来控制EGF受体配体的胞外域脱落。
另一个目的是确定胰岛素/IGF- 1之间的串扰机制,
受体和异源三聚体G蛋白,并确定的作用
异源三聚体G蛋白在胰岛素和IGF- 1受体介导的
ERK 1/2 MAP激酶级联。第三个目标是确定贡献
胰岛素/IGF- 1受体、异源三聚体G蛋白和
表皮生长因子受体对转录调控和细胞凋亡的调控
在多种胰岛素敏感细胞类型中增殖。实验将
使用永生化细胞系,以及培养的肝细胞、脂肪细胞和
肌肉细胞了解这些机制可能会导致药理学
分离潜在有害增殖效应的方法
胰岛素家族受体的抗凋亡和代谢作用。
英文摘要
DESCRIPTION: (Scanned from the applicant's abstract) In response to insulin,
glucose transporters redistribute to the plasma membrane, glucose and lipid
metabolism shifts into an anabolic mode, lipid kinases generate anti-apoptotic
signals, and tyrosine kinases stimulate cell growth. Current models propose
that insulin responses arise from the intrinsic ligand-stimulated tyrosine
kinase activity of the receptor acting upon a small subset of tyrosine
phosphoprotein adapters. Recent work, however, has begun to reveal extensive
networks of cross talk between insulin family receptors and other signal
transducers including heterotrimeric G proteins and classical receptor tyrosine
kinases. In this proposal, we provide preliminary data demonstrating that IGF-1
receptors stimulate the anti-apoptotic IRS1/Phosphatidylinositol 3-kinase/Akt
pathway and the proliferative Shc/Grb2-Sos/Ras/ERK1/2 pathway by distinct
mechanisms. Whereas IGF- 1 receptor-mediated phosphorylation of IRS proteins
controls the antiapoptotic pathway, IGF-1-induced mitogenic signaling requires
the release of epidermal growth factor (EGF)like ligands from the cell surface
and paracrine "transactivation" of EGF receptors. Cross talk between IGF- 1 and
EGF receptors is mediated by matrix metalloprotease-dependent cleavage of
heparin-binding (HB)-EGF, process which also involves pertussis toxin-sensitive
heterotrimeric G proteins. The broad goals of this proposal are to characterize
the mechanisms of cross talk between insulin/IGF-1 receptors, EGF receptors,
and heterotrimeric G proteins, and to determine contribution of these
mechanisms to transcriptional regulation and the control of cell proliferation
by insulin and IGF- 1 receptors. One specific aim of this proposal to determine
the mechanism whereby insulin and IGF- 1 receptors regulate matrix
metalloproteases to control ectodomain shedding of EGF receptor ligands.
Another aim is to determine the mechanism of cross talk between insulin/lGF- 1
receptors and heterotrimeric G proteins and to define the role of
heterotrimeric G proteins in insulin and IGF- 1 receptor-mediated activation of
the ERK1/2 MAP kinase cascade. The third aim is to determine the contribution
of cross talk between insulin/lGF- 1 receptors, heterotrimeric G proteins and
EGF receptors to transcriptional regulation and the control of cell
proliferation in a variety of insulin-sensitive cell types. Experiments will
employ immortalized cell lines, as well as cultured hepatocyte, adipocyte and
muscle cells. Understanding these mechanisms may lead to pharmacologic
approaches to dissociate the potentially harmful proliferative effects of
insulin family receptors from their anti-apoptotic and metabolic effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacodynamics of Biased G Protein-Coupled Receptor Agonism
-
批准号:9916766
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2018
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Pharmacodynamics of Biased G protein-Coupled Receptor Agonism
-
批准号:8879161
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2013
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Pharmacodynamics of Biased G protein-Coupled Receptor Agonism
-
批准号:8578152
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2013
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Pharmacodynamics of Biased G protein-Coupled Receptor Agonism
-
批准号:8680259
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2013
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Fluorometric Imaging Plate Reader (FLIPRtetra)
-
批准号:7794548
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2010
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Tyrosine Kinases in G Protein Mediated Signaling
-
批准号:8004390
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2010
-
负责人:LOUIS M LUTTRELL
-
依托单位:
STUDIES IN INFANTS FOR THE IMMUNOPATHOGENSIS OF T1D
-
批准号:7719625
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2008
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Parathyroid Hormone and Osteoblast Mitogenesis
-
批准号:6924562
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2002
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Parathyroid Hormone and Osteoblast Mitogenesis
-
批准号:6820556
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2002
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Parathyroid Hormone and Osteoblast Mitogenesis
-
批准号:6654915
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2002
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Parathyroid Hormone and Osteoblast Mitogenesis
-
批准号:6435366
-
项目类别:
-
资助金额:$33.09万
-
财政年份:2002
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Parathyroid Hormone and Osteoblast Mitogenesis
-
批准号:6780914
-
项目类别:
-
资助金额:$17.96万
-
财政年份:2002
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Receptor 'transactivation' in insulin signaling.
-
批准号:6751198
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2001
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Receptor 'transactivation' in insulin signaling.
-
批准号:6819672
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2001
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Receptor 'transactivation' in insulin signaling.
-
批准号:6517816
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2001
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Receptor 'transactivation' in insulin signaling.
-
批准号:6327035
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2001
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Tyrosine kinases in G protein mediated signaling.
-
批准号:7104966
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1998
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Tyrosine Kinases in G Protein Mediated Signaling
-
批准号:7655949
-
项目类别:
-
资助金额:$28.36万
-
财政年份:1998
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Tyrosine Kinases in G Protein Mediated Signaling
-
批准号:8894489
-
项目类别:
-
资助金额:$32.52万
-
财政年份:1998
-
负责人:LOUIS M LUTTRELL
-
依托单位:
Tyrosine Kinases in G Protein Mediated Signaling
-
批准号:7858356
-
项目类别:
-
资助金额:$35.05万
-
财政年份:1998
-
负责人:LOUIS M LUTTRELL
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: